Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710
Top Cited Papers
Open Access
- 11 November 2010
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 116 (19), 3751-3757
- https://doi.org/10.1182/blood-2010-02-269621
Abstract
Arsenic trioxide (As2O3) is a highly effective treatment for patients with relapsed acute promyelocytic leukemia (APL); its role as consolidation treKeywords
This publication has 36 references indexed in Scilit:
- Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemiaProceedings of the National Academy of Sciences, 2009
- Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA resultsBlood, 2008
- Is Cytarabine Useful in the Treatment of Acute Promyelocytic Leukemia? Results of a Randomized Trial From the European Acute Promyelocytic Leukemia GroupJournal of Clinical Oncology, 2006
- Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicityBlood, 2006
- Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapyAnnals Of Oncology, 2005
- Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA groupBlood, 2003
- Effect of Arsenic Trioxide on QT Interval in Patients With Advanced MalignanciesJournal of Clinical Oncology, 2003
- Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic TrioxideNew England Journal of Medicine, 1998
- TRANSLOCATION OF THE RARα LOCUS TO THE PML OR PLZF GENE IN ACUTE PROMYELOCYTIC LEUKAEMIABritish Journal of Haematology, 1994
- Morphologic and cytochemical characteristics of acute promyelocytic leukemiaAmerican Journal of Hematology, 1989